Daiwa Securities Group Inc. Abb Vie Inc. Transaction History

Daiwa Securities Group Inc.

$21.6 Billion
Q3 2024

A detailed history of Daiwa Securities Group Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 224,822 shares of ABBV stock, worth $38.1 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

224,822

Previous 203,493 10.48%

Holding current value

$38.1 Million

Previous $34.9 Million 27.2%

% of portfolio

0.21%

Previous 0.19%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $3.49 Million - $4.25 Million	21,329 Added 10.48%	224,822 $44.4 Million
Q2 2024 Aug 07, 2024	BUY	$154.79 - $180.76 $1.69 Million - $1.97 Million	10,904 Added 5.66%	203,493 $34.9 Million
Q1 2024 May 02, 2024	BUY	$159.82 - $182.1 $3.87 Million - $4.41 Million	24,202 Added 14.37%	192,589 $35.1 Million
Q4 2023 Jan 31, 2024	BUY	$137.6 - $154.97 $1.62 Million - $1.82 Million	11,775 Added 7.52%	168,387 $26.1 Million
Q3 2023 Nov 01, 2023	BUY	$133.59 - $154.65 $1.23 Million - $1.42 Million	9,179 Added 6.23%	156,612 $23.3 Million
Q2 2023 Jul 31, 2023	BUY	$132.51 - $164.9 $515,463 - $641,461	3,890 Added 2.71%	147,433 $19.9 Million
Q1 2023 May 02, 2023	BUY	$144.61 - $166.54 $1.63 Million - $1.88 Million	11,264 Added 8.52%	143,543 $22.9 Million
Q4 2022 Feb 06, 2023	BUY	$138.31 - $165.87 $1.17 Million - $1.4 Million	8,437 Added 6.81%	132,279 $21.4 Million
Q3 2022 Nov 02, 2022	SELL	$134.21 - $153.93 $2.57 Million - $2.94 Million	-19,127 Reduced 13.38%	123,842 $16.6 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $1.09 Million - $1.38 Million	7,909 Added 5.86%	142,969 $21.9 Million
Q1 2022 Apr 29, 2022	BUY	$131.98 - $163.75 $1.37 Million - $1.7 Million	10,406 Added 8.35%	135,060 $21.9 Million
Q4 2021 Feb 03, 2022	BUY	$107.43 - $135.93 $2.38 Million - $3.02 Million	22,195 Added 21.66%	124,654 $16.9 Million
Q3 2021 Nov 05, 2021	SELL	$106.4 - $120.78 $104,910 - $119,089	-986 Reduced 0.95%	102,459 $11.1 Million
Q2 2021 Aug 06, 2021	SELL	$105.21 - $117.21 $2.17 Million - $2.42 Million	-20,653 Reduced 16.64%	103,445 $11.7 Million
Q1 2021 May 03, 2021	SELL	$102.3 - $112.62 $3.38 Million - $3.72 Million	-33,038 Reduced 21.03%	124,098 $13.4 Million
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $4.91 Million - $6.63 Million	61,056 Added 63.55%	157,136 $16.8 Million
Q3 2020 Nov 02, 2020	BUY	$85.91 - $100.83 $1.38 Million - $1.61 Million	16,012 Added 20.0%	96,080 $8.42 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $1.21 Million - $1.84 Million	-18,829 Reduced 19.04%	80,068 $6.1 Million
Q4 2019 Jan 31, 2020	BUY	$72.13 - $90.25 $355,095 - $444,300	4,923 Added 5.24%	98,897 $8.76 Million
Q3 2019 Nov 04, 2019	BUY	$62.98 - $75.72 $388,964 - $467,646	6,176 Added 7.03%	93,974 $7.12 Million
Q2 2019 Jul 24, 2019	BUY	$65.7 - $83.98 $788,400 - $1.01 Million	12,000 Added 15.83%	87,798 $6.39 Million
Q1 2019 Apr 26, 2019	BUY	$77.14 - $90.79 $833,189 - $980,622	10,801 Added 16.62%	75,798 $6.11 Million
Q4 2018 Feb 05, 2019	BUY	$77.85 - $96.01 $76,293 - $94,089	980 Added 1.53%	64,997 $5.99 Million
Q3 2018 Nov 01, 2018	SELL	$88.91 - $98.84 $535,060 - $594,819	-6,018 Reduced 8.59%	64,017 $6.06 Million
Q2 2018 Jul 30, 2018	BUY	$89.78 - $106.23 $94,269 - $111,541	1,050 Added 1.52%	70,035 $6.49 Million
Q1 2018 May 02, 2018	BUY	$92.01 - $123.21 $1.37 Million - $1.83 Million	14,888 Added 27.52%	68,985 $6.53 Million
Q4 2017 Feb 06, 2018	SELL	$89.56 - $98.21 $1.15 Million - $1.26 Million	-12,870 Reduced 19.22%	54,097 $5.23 Million
Q3 2017 Nov 02, 2017	BUY	$69.85 - $89.22 $4.68 Million - $5.97 Million	66,967	66,967 $5.95 Million

Others Institutions Holding ABBV

# of Institutions

3,837

Shares Held

1.25B

Call Options Held

15.7M

Put Options Held

11.3M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $300B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Account

Daiwa Securities Group Inc. Abb Vie Inc. Transaction History